Founded in 2015, launched in 2016, and based in Cambridge, Massachusetts, Magenta is making rapid progress in discovering, developing, and commercializing products to transform bone marrow transplant and expand its use in a wide range of disease settings.
In 2017, we were named one for Fierce Biotech’s “Fierce 15” companies; the “Hottest Early Stage Startup” in Healthcare at the NEVY Awards, sponsored by the New England Venture Capital Association and raised more than $98 million in funding through two private rounds. With this support we are pursuing multiple clinical strategies, including a lead program in Phase 2 testing.
We offer competitive compensation along with a comprehensive benefits package. To apply, please submit your resume to firstname.lastname@example.org
Magenta Therapeutics is an equal opportunity employer and will not discriminate against any employee or applicant based on age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.